Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model

Claire Colenutt; Simon M Cutting

doi:10.1111/1574-6968.12468

Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	154-61
Number of pages	8
Journal	FEMS Microbiology Letters
Volume	358
Issue number	2
DOIs	https://doi.org/10.1111/1574-6968.12468
Publication status	Published - 29 May 2014

Keywords

Administration, Oral
Animals
Bacillus subtilis
Clostridium Infections
Clostridium difficile
Disease Models, Animal
Female
Mice, Inbred C57BL
Probiotics
Spores, Bacterial
Treatment Outcome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/1574-6968.12468

Cite this

@article{cc0ae07ed7aa4bfe86d75ea006b21f5a,

title = "Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model",

keywords = "Administration, Oral, Animals, Bacillus subtilis, Clostridium Infections, Clostridium difficile, Disease Models, Animal, Female, Mice, Inbred C57BL, Probiotics, Spores, Bacterial, Treatment Outcome",

author = "Claire Colenutt and Cutting, {Simon M}",

year = "2014",

month = may,

day = "29",

doi = "10.1111/1574-6968.12468",

language = "English",

volume = "358",

pages = "154--61",

journal = "FEMS Microbiology Letters",

issn = "0378-1097",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model

AU - Colenutt, Claire

AU - Cutting, Simon M

PY - 2014/5/29

Y1 - 2014/5/29

KW - Administration, Oral

KW - Animals

KW - Bacillus subtilis

KW - Clostridium Infections

KW - Clostridium difficile

KW - Disease Models, Animal

KW - Female

KW - Mice, Inbred C57BL

KW - Probiotics

KW - Spores, Bacterial

KW - Treatment Outcome

U2 - 10.1111/1574-6968.12468

DO - 10.1111/1574-6968.12468

M3 - Article

C2 - 24828432

SN - 0378-1097

VL - 358

SP - 154

EP - 161

JO - FEMS Microbiology Letters

JF - FEMS Microbiology Letters

IS - 2

ER -